OrbiMed And GE Invest $20M In ‘Ornim Medical’

GE Helathcare, together with OrbiMed Israel, announced a $20 million investment in Ornim, a developer of the CerOx monitor that non-invasively monitors blood flow and oxygen saturation in brain and muscle tissue. The investment was made as part of a financing round led by OrbiMed, also including Agate Medical Investment Fund. The financing will be used for further development, clinical studies, international marketing and commercialization of Ornim’s CerOx monitor. Ornim Medical, based in Lod, Israel, was founded in 2004.